Well it looks as if all the crusaders who claim that the “high” out of pocket cost of insulin is hurting patients will get their day in court. The Minnesota Attorney General is suing the three major insulin companies – Lilly – Novo Nordisk and Sanofi. Per several published reports;
“The lawsuit claims drugmakers fraudulently set "artificially high" list prices for their drugs and negotiated steep rebates with pharmacy benefit managers. This practice allegedly made the drugmakers' insulin more profitable for PBMs and in turn made the middlemen more inclined to place the drug on their formularies, or list of approved drugs . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.